p53 antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20

被引:21
作者
Jabbur, JR
Zhang, W
机构
[1] Univ Texas, MD Anderson Canc Ctr, Canc Genom Lab, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Grad Program Canc Biol, Houston, TX 77030 USA
关键词
mutagenesis; Mdm-2; p21(Waf1/Cip1); Fas/APO-1; transactivation; protein conformation; growth regulation;
D O I
10.4161/cbt.81
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have demonstrated the irradiation-induced phosphorylation of p53 at Thr18 and Ser20, residues integral within an a-helical segment of the transactivation domain. Importantly, phosphorylation at either site has been correlated with decreased binding to the inhibitory partner Mdm-2 and enhanced transactivation of p53 target genes. In this study, we investigated the impact of Asp substitution at Thr18 and Ser20 (p53T18D/S20D) on the functional regulation of p53. Asp substitution is commonly accepted as a means of mimicking phosphorylation due to the introduction of negative charge within the functional group. p53T18D/S20D was refractory to in vitro digestion by calpain, a protease recognizing a-helical structure within the transactivation domain. In addition, transfected p53T18D/S20D poorly bound GST-Mdm-2 in vitro, enhanced the endogenous expression of the p53 transactivation targets p21(Waf1/Cip1) and fas/APO-1, and significantly curtailed cell proliferation relative to wild-type p53 transfected cells. Thus, Asp substitution at Thr18 and Ser20 within the a-helical segment of the transactivation domain reduced Mdm-2 interaction, upregulating transactivation of cell-cycle and apoptotic regulatory targets, curtailing cellular proliferation.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 64 条
[1]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[2]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[3]   Comparative study of the p53-mdm2 and p53-MDMX interfaces [J].
Böttger, V ;
Böttger, A ;
Garcia-Echeverria, C ;
Ramos, YFM ;
van der Eb, AJ ;
Jochemsen, AG ;
Lane, DP .
ONCOGENE, 1999, 18 (01) :189-199
[4]   Activation mechanism of the MAP kinase ERK2 by dual phosphorylation [J].
Canagarajah, BJ ;
Khokhlatchev, A ;
Cobb, MH ;
Goldsmith, EJ .
CELL, 1997, 90 (05) :859-869
[5]   p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage [J].
Chao, C ;
Saito, S ;
Kang, J ;
Anderson, CW ;
Appella, E ;
Xu, Y .
EMBO JOURNAL, 2000, 19 (18) :4967-4975
[6]  
Chehab NH, 2000, GENE DEV, V14, P278
[7]   Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage [J].
Chehab, NH ;
Malikzay, A ;
Stavridi, ES ;
Halazonetis, TD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13777-13782
[8]   Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers [J].
Craig, AL ;
Burch, L ;
Vojtesek, B ;
Mikutowska, J ;
Thompson, A ;
Hupp, TR .
BIOCHEMICAL JOURNAL, 1999, 342 :133-141
[9]   The loss of mdm2 induces p53 mediated apoptosis [J].
de Rozieres, S ;
Maya, R ;
Oren, M ;
Lozano, G .
ONCOGENE, 2000, 19 (13) :1691-1697
[10]   ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation [J].
de Toledo, SM ;
Azzam, EI ;
Dahlberg, WK ;
Gooding, TB ;
Little, JB .
ONCOGENE, 2000, 19 (54) :6185-6193